Clinical Trial Update: The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing nitroglycerin for correcting microcirculatory abnormalities in sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Frisius Medisch Centrum | Conditions: Sepsis, Septic Shock | Phase 3 | Status: COMPLETED